A Double-Blind, Placebo Controlled, Randomized Study to Evaluate the Safety and Tolerability of INCB019602 Plus Metformin Compared to Metformin Alone in Type 2 Diabetic Subjects.
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2012
At a glance
- Drugs INCB 19602 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 21 Jun 2010 Planned end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 11 May 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 23 Feb 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.